Collier Kathryn J

Average Profitability
<0.0001%
Insider Buys Quantity
2
Insider Buys Sum
$17,291.00
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Collier Kathryn J

According to the SEC Form 4 filings, Collier Kathryn J, being in a position of

  1. director at Regulus Therapeutics Inc.,
    оver the last 12 months, has bought 4000 shares for $7,280, and sold 0 shares,
    over all time since 2018-11-16, has bought 11100 shares for $17,291, and sold 0 shares.

The largest purchase of all time was on 2018-11-16 and amounted to 7100 shares of Regulus Therapeutics Inc. for $10,011.

Biography of Collier Kathryn J

No biography is available at this moment.

2024-07-25PurchaseRegulus Therapeutics Inc.
RGLS
director
4,000
0.0063%
$1.82$7,280-10.23%
2018-11-16PurchaseRegulus Therapeutics Inc.
RGLS
director
7,100
0.0797%
$1.41$10,011-27.78%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.